These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 33465149)

  • 21. The Tat Inhibitor Didehydro-Cortistatin A Prevents HIV-1 Reactivation from Latency.
    Mousseau G; Kessing CF; Fromentin R; Trautmann L; Chomont N; Valente ST
    mBio; 2015 Jul; 6(4):e00465. PubMed ID: 26152583
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Establishment of a Novel Humanized Mouse Model To Investigate
    Flerin NC; Bardhi A; Zheng JH; Korom M; Folkvord J; Kovacs C; Benko E; Truong R; Mota T; Connick E; Jones RB; Lynch RM; Goldstein H
    J Virol; 2019 Mar; 93(6):. PubMed ID: 30626677
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High levels of CD2 expression identify HIV-1 latently infected resting memory CD4+ T cells in virally suppressed subjects.
    Iglesias-Ussel M; Vandergeeten C; Marchionni L; Chomont N; Romerio F
    J Virol; 2013 Aug; 87(16):9148-58. PubMed ID: 23760244
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proteomic Profiling of a Primary CD4
    Saha JM; Liu H; Hu PW; Nikolai BC; Wu H; Miao H; Rice AP
    AIDS Res Hum Retroviruses; 2018 Jan; 34(1):103-110. PubMed ID: 29084447
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Naf1 Regulates HIV-1 Latency by Suppressing Viral Promoter-Driven Gene Expression in Primary CD4+ T Cells.
    Li C; Wang HB; Kuang WD; Ren XX; Song ST; Zhu HZ; Li Q; Xu LR; Guo HJ; Wu L; Wang JH
    J Virol; 2017 Jan; 91(1):. PubMed ID: 27795436
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chimeric Antigen Receptor T Cells Guided by the Single-Chain Fv of a Broadly Neutralizing Antibody Specifically and Effectively Eradicate Virus Reactivated from Latency in CD4+ T Lymphocytes Isolated from HIV-1-Infected Individuals Receiving Suppressive Combined Antiretroviral Therapy.
    Liu B; Zou F; Lu L; Chen C; He D; Zhang X; Tang X; Liu C; Li L; Zhang H
    J Virol; 2016 Nov; 90(21):9712-9724. PubMed ID: 27535056
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CTL Clonotypes with Higher TCR Affinity Have Better Ability to Reduce the HIV Latent Reservoir.
    Lima NS; Takata H; Huang SH; Haregot A; Mitchell J; Blackmore S; Garland A; Sy A; Cartwright P; Routy JP; Michael NL; Appay V; Jones RB; Trautmann L
    J Immunol; 2020 Aug; 205(3):699-707. PubMed ID: 32591402
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Toll-Like Receptor 2 Ligation Enhances HIV-1 Replication in Activated CCR6+ CD4+ T Cells by Increasing Virus Entry and Establishing a More Permissive Environment to Infection.
    Bolduc JF; Ouellet M; Hany L; Tremblay MJ
    J Virol; 2017 Feb; 91(4):. PubMed ID: 27928019
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impaired IL-2 expression in latent HIV-1 infection.
    Shin Y; Yoon CH; Lim H; Park J; Roh TY; Kang C; Choi BS
    Biochem Biophys Res Commun; 2015 Aug; 463(4):1237-42. PubMed ID: 26086100
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A broad drug arsenal to attack a strenuous latent HIV reservoir.
    Stoszko M; Ne E; Abner E; Mahmoudi T
    Curr Opin Virol; 2019 Oct; 38():37-53. PubMed ID: 31323521
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combination of biological screening in a cellular model of viral latency and virtual screening identifies novel compounds that reactivate HIV-1.
    Gallastegui E; Marshall B; Vidal D; Sanchez-Duffhues G; Collado JA; Alvarez-Fernández C; Luque N; Terme JM; Gatell JM; Sánchez-Palomino S; Muñoz E; Mestres J; Verdin E; Jordan A
    J Virol; 2012 Apr; 86(7):3795-808. PubMed ID: 22258251
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reactivation Kinetics of HIV-1 and Susceptibility of Reactivated Latently Infected CD4+ T Cells to HIV-1-Specific CD8+ T Cells.
    Walker-Sperling VE; Cohen VJ; Tarwater PM; Blankson JN
    J Virol; 2015 Sep; 89(18):9631-8. PubMed ID: 26178987
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of Biological Sex, Age, and HIV Status in an In Vitro Primary Cell Model of HIV Latency Using a CXCR4 Tropic Virus.
    Macedo AB; Resop RS; Martins LJ; Szaniawski MA; Sorensen ES; Spivak AM; Nixon DF; Jones RB; Planelles V; Bosque A
    AIDS Res Hum Retroviruses; 2018 Sep; 34(9):769-777. PubMed ID: 29926732
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Higher expression of human telomerase reverse transcriptase in productively-infected CD4 cells possibly indicates a mechanism for persistence of the virus in HIV infection.
    Suryawanshi P; Godbole S; Pawar J; Thakar M; Shete A
    Microbiol Immunol; 2018 May; 62(5):317-326. PubMed ID: 29577368
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor suppressor cylindromatosis (CYLD) controls HIV transcription in an NF-κB-dependent manner.
    Manganaro L; Pache L; Herrmann T; Marlett J; Hwang Y; Murry J; Miorin L; Ting AT; König R; García-Sastre A; Bushman FD; Chanda SK; Young JA; Fernandez-Sesma A; Simon V
    J Virol; 2014 Jul; 88(13):7528-40. PubMed ID: 24760882
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of HIV-1 latency by T-cell activation.
    Williams SA; Greene WC
    Cytokine; 2007 Jul; 39(1):63-74. PubMed ID: 17643313
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibody-Mediated CD4 Depletion Induces Homeostatic CD4
    Kumar NA; McBrien JB; Carnathan DG; Mavigner M; Mattingly C; White ER; Viviano F; Bosinger SE; Chahroudi A; Silvestri G; Paiardini M; Vanderford TH
    J Virol; 2018 Nov; 92(22):. PubMed ID: 30185596
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enumeration of latently infected CD4+ T cells from HIV-1-infected patients using an HIV-1 antigen ELISPOT assay.
    Fondere JM; Planas JF; Huguet MF; Baillat V; Bolos F; Reynes J; Vendrell JP
    J Clin Virol; 2004 Jan; 29(1):33-8. PubMed ID: 14675867
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Single-cell RNA sequencing reveals common and unique gene expression profiles in primary CD4+ T cells latently infected with HIV under different conditions.
    Zhang X; Qazi AA; Deshmukh S; Lobato Ventura R; Mukim A; Beliakova-Bethell N
    Front Cell Infect Microbiol; 2023; 13():1286168. PubMed ID: 38156317
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HIV Envelope gp120 Alters T Cell Receptor Mobilization in the Immunological Synapse of Uninfected CD4 T Cells and Augments T Cell Activation.
    Deng J; Mitsuki YY; Shen G; Ray JC; Cicala C; Arthos J; Dustin ML; Hioe CE
    J Virol; 2016 Dec; 90(23):10513-10526. PubMed ID: 27630246
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.